TATIANA HICKENBOTTOM: Open Payments
NPI 1376019513 · LEANDER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,732 in 165 payments from 16 companies in 2025. Trend: 2023 $1,386 · 2024 $2,391 · 2025 $3,732
Food & beverage: $2,682Consulting: $1,050
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 34 | $1,684 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 26 | $346 |
| Phathom Pharmaceuticals, Inc. | 26 | $256 |
| PFIZER INC. | 21 | $239 |
| ABBVIE INC. | 9 | $222 |
| Celltrion USA Inc. | 11 | $219 |
| Aimmune Therapeutics, Inc. | 12 | $156 |
| Novo Nordisk Inc | 2 | $120 |
| Lilly USA, LLC | 5 | $95 |
| Madrigal Pharmaceuticals | 4 | $84 |
Products named: TREMFYA, XIFAXAN, VOQUEZNA, VELSIPITY, VEGZELMA, ZENPEP, Wegovy, LINZESS.
Industry payments across TX — which companies pay providers there.
